Lindenane sesquiterpenoid dimers from Chloranthus japonicus improve LDL uptake by regulating PCSK9 and LDLR

被引:5
|
作者
Guo, Pengju [1 ,2 ]
Chen, Tong [2 ,3 ]
Hu, Xianggang [2 ,3 ]
Duan, Yelin [2 ,3 ]
Zheng, Liu [2 ]
Du, Gaoxiang [2 ,3 ]
Wang, Qing [2 ,3 ]
Ding, Aoxue [2 ]
Qin, Guoqing [2 ]
Chen, Yihan [2 ,3 ]
Wang, Wenqiong [2 ]
Mu, Qing [1 ,2 ]
Xuan, Lijiang [2 ,3 ]
机构
[1] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
[3] Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210029, Peoples R China
关键词
Chloranthus japonicas; Lindenane sesquiterpenoid dimers; PCSK9; LDLR; CHEMICAL-CONSTITUENTS; C-F; PLANTS; ROOTS; CHLORAHOLOLIDE; BLOCKERS; POTENT;
D O I
10.1016/j.bioorg.2023.106958
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
UPLC-TOF-MS/MDF directed phytochemical research of Chloranthus japonicus led to the isolation of 46 lindenane sesquiterpenoid dimers, which included 13 new analogs. Their structures with absolute configurations were elucidated by analysis of spectroscopic data. Fourteen compounds with ester chains significantly decreased PCSK9 protein level in medium of HepG2 cells, especially for compounds 14 and 29 (5 mu M) with inhibition rates of 69.0% and 72.8%, respectively. Compound 14 in HepG2 cells was evaluated via DiI-LDL uptake assays and found to increase LDL uptake by upregulating LDLR mRNA and protein level. Meanwhile, 14 decreased the secretion of PCSK9 protein in medium and downregulated intracellular PCSK9 protein and mRNA level. The discovery of these natural small molecule compounds provides a novel structure basis for design PCSK9 regulators, making them a promising lead for development of new lipid-lowering agents.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Mechanistic implications for LDL receptor degradation from the PCSK9/LDLR structure at neutral pH
    Lo Surdo, Paola
    Bottomley, Matthew J.
    Calzetta, Alessandra
    Settembre, Ethan C.
    Cirillo, Agostino
    Pandit, Shilpa
    Ni, Yan G.
    Hubbard, Brian
    Sitlani, Ayesha
    Carfi, Andrea
    EMBO REPORTS, 2011, 12 (12) : 1300 - 1305
  • [22] PCSK9 and LDLR The Yin-Yang in the Cellular Uptake of Cholesterol
    Morales-Villegas, Enrique
    CURRENT HYPERTENSION REVIEWS, 2013, 9 (04) : 310 - 323
  • [23] The proteasome inhibitor MG132 enhances LDL uptake in hepatocytes through regulating LDLR and PCSK9 expression: a novel role in cholesterol homeostasis
    Yan, Hong
    Ma, Yan-ling
    Wang, Xin-bo
    Gui, Yu-zhou
    Gao, Fei
    Wang, Yi-ping
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 95 - 95
  • [24] Highly Fused Lindenane Sesquiterpenoid Dimers with Apoptosis-Inducing Properties from Chloranthus holostegius var. shimianensis
    Xiao, Long-Gao
    Huang, Jia-Xin
    Yan, Huan
    Li, Yan-Xi
    Yang, Xue-Yu
    Ni, Wei
    Fang, Xin
    Liu, Hui
    Liu, Hai-Yang
    JOURNAL OF ORGANIC CHEMISTRY, 2025, 90 (11): : 4062 - 4069
  • [25] Effects of LDL and oxLDL on expression of PCSK9 and LDLR in THP-1 macrophages
    Liu Lu-Shan
    Cheng Yan-Li
    Xie Min
    Yang Qiong
    Pan Li-Hong
    Jiang Zhi-Sheng
    Tang Chao-Ke
    Wei Dang-Heng
    Tang Zhi-Han
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2008, 35 (05) : 540 - 547
  • [26] Lindenane sesquiterpenoid dimers with NLRP3 inflammasome inhibitory activities from Chloranthus holostegius var. shimianensis
    Xiao, Longgao
    Yan, Huan
    Yang, Songxue
    Liu, Hui
    Li, Yanxi
    Fang, Xin
    Ni, Wei
    Zhang, Xingjie
    Xiao, Weilie
    Liu, Haiyang
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 177
  • [27] Chlospicenes A and B, cyclopropane cracked lindenane sesquiterpenoid dimers with anti-nonalcoholic steatohepatitis activity from Chloranthus henryi
    Jixin Li
    Zhirong Cui
    Yongyi Li
    Chunhua Han
    Yanqiu Zhang
    Pengfei Tang
    Letian Cui
    Hao Zhang
    Jun Luo
    Lingyi Kong
    ChineseChemicalLetters, 2022, 33 (09) : 4257 - 4260
  • [28] Chlospicenes A and B, cyclopropane cracked lindenane sesquiterpenoid dimers with anti-nonalcoholic steatohepatitis activity from Chloranthus henryi
    Li, Jixin
    Cui, Zhirong
    Li, Yongyi
    Han, Chunhua
    Zhang, Yanqiu
    Tang, Pengfei
    Cui, Letian
    Zhang, Hao
    Luo, Jun
    Kong, Lingyi
    CHINESE CHEMICAL LETTERS, 2022, 33 (09) : 4257 - 4260
  • [29] A PCSK9 C-terminal Domain Binding Fab Inhibits PCSK9 Internalization and Restores LDL-uptake
    Ni, Yan G.
    Condra, Jon H.
    Di Marco, Stefania
    Orsatti, Laura
    Shen, Xun
    Pandit, Shilpa
    Bottomley, Matthew J.
    Ruggeri, Lionello
    Cummings, Richard T.
    Cubbon, Rose M.
    Santoro, Joseph C.
    Fisher, Timothy S.
    Lo Surdo, Paola
    Talamo, Fabio
    Wood, Dana D.
    Hammond, Holly A.
    Wisniewski, Douglas
    Volpari, Cinzia
    Njimoluh, Leila
    Ha, Sookhee
    Hubbard, Brian
    Carfi, Andrea
    Sitlani, Ayesha
    CIRCULATION, 2009, 120 (18) : S477 - S477
  • [30] Thyroid stimulating hormone exhibits the impact on LDLR/LDL-c via up-regulating hepatic PCSK9 expression
    Gong, Yingyun
    Ma, Yizhe
    Ye, Zhengqin
    Fu, Zhenzhen
    Yang, Panpan
    Gao, Beibei
    Guo, Wen
    Hu, Dandan
    Ye, Jingya
    Ma, Shuai
    Zhang, Fan
    Zhou, Li
    Xu, Xinyu
    Li, Zhong
    Yang, Tao
    Zhou, Hongwen
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 76 : 32 - 41